Nephrocare Health Services Limited Share Price & Analysis
₹626.5▼ -0.37%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹626.5
-0.37%
Open
₹—
High
₹640.25
Low
₹618
Close
₹626.5
52W High
₹770
52W Low
₹445
Volume
159K
Lot Size
1
Sector
Healthcare
Market Cap
₹6K Cr
Face Value
₹2
Mid Cap
Price Chart
Fundamentals
P/E
83.2
Sector P/E
54.4
P/B
1.69
EPS
₹8.08
ROE
9.06%
ROCE
15.5%
D/E Ratio
0.07
Div Yield
0%
Book Value
₹111
+
Strengths
- ✓Efficient capital deployment (ROCE 15.5%)
- ✓Virtually debt-free
−
Concerns
- ✗Premium to sector peers (P/E 83.2x vs industry 54.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Revenue | ₹266 Cr ▲2.3% | ₹260 Cr ▲5.7% | ₹246 Cr ▲12.3% | ₹219 Cr ▲11.2% | ₹197 Cr |
| Op. Profit | ₹51 Cr ▼16.4% | ₹61 Cr ▼4.7% | ₹64 Cr ▲25.5% | ₹51 Cr ▲15.9% | ₹44 Cr |
| OPM | 19.0% ▼17.4% | 23.0% ▼11.5% | 26.0% ▲13.0% | 23.0% ▲4.5% | 22.0% |
| Net Profit | ₹30 Cr ▼6.3% | ₹32 Cr ▲455.6% | ₹-9 Cr ▼136.0% | ₹25 Cr ▲25.0% | ₹20 Cr |
| EPS (₹) | 3.03 ▼5.6% | 3.21 ▲161.3% | -5.24 ▼104.4% | 119.3 ▲23.6% | 96.5 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹999 Cr ▲32.1% | ₹756 Cr ▲33.6% | ₹566 Cr ▲29.5% | ₹437 Cr ▲37.4% | ₹318 Cr ▲11.2% | ₹286 Cr |
| Expenses | ₹775 Cr ▲31.6% | ₹589 Cr ▲26.7% | ₹465 Cr ▲19.5% | ₹389 Cr ▲28.8% | ₹302 Cr ▲21.8% | ₹248 Cr |
| Op. Profit | ₹224 Cr ▲34.1% | ₹167 Cr ▲65.3% | ₹101 Cr ▲106.1% | ₹49 Cr ▲206.3% | ₹16 Cr ▼56.8% | ₹37 Cr |
| OPM | 22.0% ▲0.0% | 22.0% ▲22.2% | 18.0% ▲63.6% | 11.0% ▲120.0% | 5.0% ▼61.5% | 13.0% |
| Other Income | ₹25 Cr ▲78.6% | ₹14 Cr ▲75.0% | ₹8 Cr ▲33.3% | ₹6 Cr ▼40.0% | ₹10 Cr ▲100.0% | ₹5 Cr |
| Interest | ₹60 Cr ▲185.7% | ₹21 Cr ▲5.0% | ₹20 Cr ▲25.0% | ₹16 Cr ▲60.0% | ₹10 Cr ▲42.9% | ₹7 Cr |
| Depreciation | ₹91 Cr ▲26.4% | ₹72 Cr ▲28.6% | ₹56 Cr ▲19.1% | ₹47 Cr ▲11.9% | ₹42 Cr ▲23.5% | ₹34 Cr |
| PBT | ₹97 Cr ▲11.5% | ₹87 Cr ▲163.6% | ₹33 Cr ▲466.7% | ₹-9 Cr ▲66.7% | ₹-27 Cr ▼2800.0% | ₹1 Cr |
| Tax % | 21.0% ▼8.7% | 23.0% ▲483.3% | -6.0% ▼116.2% | 37.0% ▲276.2% | -21.0% ▼167.7% | 31.0% |
| Net Profit | ₹77 Cr ▲14.9% | ₹67 Cr ▲91.4% | ₹35 Cr ▲391.7% | ₹-12 Cr ▲42.9% | ₹-21 Cr ▼2200.0% | ₹1 Cr |
| EPS (₹) | 7.66 ▼97.6% | 321.87 ▲89.5% | 169.82 ▲389.4% | -58.69 ▲45.1% | -106.93 ▼3245.0% | 3.4 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Liabilities | ||||||
| Equity Capital | ₹20 Cr ▲900.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr |
| Reserves | ₹1.1K Cr ▲89.3% | ₹579 Cr ▲41.6% | ₹409 Cr ▲6.5% | ₹384 Cr ▼1.8% | ₹391 Cr ▲59.6% | ₹245 Cr |
| Borrowings | ₹80 Cr ▼69.3% | ₹261 Cr ▼3.7% | ₹271 Cr ▲35.5% | ₹200 Cr ▲68.1% | ₹119 Cr ▼15.0% | ₹140 Cr |
| Other Liabilities | ₹275 Cr ▲79.7% | ₹153 Cr ▲23.4% | ₹124 Cr ▲53.1% | ₹81 Cr ▲37.3% | ₹59 Cr ▲40.5% | ₹42 Cr |
| Total Liabilities | ₹1.5K Cr ▲48.0% | ₹994 Cr ▲23.3% | ₹806 Cr ▲21.0% | ₹666 Cr ▲16.6% | ₹571 Cr ▲33.4% | ₹428 Cr |
| Assets | ||||||
| Fixed Assets | ₹517 Cr ▲30.6% | ₹396 Cr ▲11.2% | ₹356 Cr ▲49.0% | ₹239 Cr ▲16.6% | ₹205 Cr ▲6.8% | ₹192 Cr |
| CWIP | ₹6 Cr ▲0.0% | ₹6 Cr ▲500.0% | ₹1 Cr ▼97.1% | ₹34 Cr ▼20.9% | ₹43 Cr ▲2050.0% | ₹2 Cr |
| Investments | ₹178 Cr ▲249.0% | ₹51 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹771 Cr ▲42.3% | ₹542 Cr ▲20.7% | ₹449 Cr ▲14.2% | ₹393 Cr ▲22.0% | ₹322 Cr ▲37.6% | ₹234 Cr |
| Total Assets | ₹1.5K Cr ▲48.0% | ₹994 Cr ▲23.3% | ₹806 Cr ▲21.0% | ₹666 Cr ▲16.6% | ₹571 Cr ▲33.4% | ₹428 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Operating CF | ₹233 Cr ▲72.6% | ₹135 Cr ▲87.5% | ₹72 Cr ▲554.5% | ₹11 Cr ▼21.4% | ₹14 Cr ▼56.3% | ₹32 Cr |
| Investing CF | ₹-410 Cr ▼228.0% | ₹-125 Cr ▼140.4% | ₹-52 Cr ▲31.6% | ₹-76 Cr ▲41.5% | ₹-130 Cr ▼109.7% | ₹-62 Cr |
| Financing CF | ₹157 Cr ▲190.7% | ₹54 Cr ▲100.0% | ₹27 Cr ▼55.0% | ₹60 Cr ▼50.4% | ₹121 Cr ▲236.1% | ₹36 Cr |
| Net Cash Flow | ₹-21 Cr ▼132.3% | ₹65 Cr ▲38.3% | ₹47 Cr ▲1275.0% | ₹-4 Cr ▼166.7% | ₹6 Cr ▲20.0% | ₹5 Cr |
| Free Cash Flow | ₹113 Cr ▲222.9% | ₹35 Cr ▲537.5% | ₹-8 Cr ▲87.1% | ₹-62 Cr ▲3.1% | ₹-64 Cr ▼120.7% | ₹-29 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Debtor Days | 116d ▼10.1% | 129d ▼1.5% | 131d ▼0.8% | 132d ▲7.3% | 123d ▲21.8% | 101d |
| Inventory Days | 53d | — | — | 67d ▲34.0% | 50d ▼23.1% | 65d |
| Days Payable | 230d | — | — | 63d ▼10.0% | 70d ▲25.0% | 56d |
| Cash Conv. Cycle | -61d ▼147.3% | 129d ▼1.5% | 131d ▼4.4% | 137d ▲33.0% | 103d ▼6.4% | 110d |
| Working Capital Days | 104d ▲285.2% | 27d ▼51.8% | 56d ▲194.7% | 19d ▼65.5% | 55d ▲111.5% | 26d |
| ROCE | 15.0% ▲7.1% | 14.0% ▲75.0% | 8.0% ▲700.0% | 1.0% ▲125.0% | -4.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Nephrocare Health Services Limited share price today?▾
Nephrocare Health Services Limited (NEPHROPLUS) is currently trading at ₹626.5 on NSE, down 0.37% as of the last market session. Prices update daily after market close on MarketNetra.
Is Nephrocare Health Services Limited available in F&O (Futures & Options)?▾
Yes, Nephrocare Health Services Limited (NEPHROPLUS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Nephrocare Health Services Limited 52-week high and low?▾
Nephrocare Health Services Limited's 52-week high is ₹770 and the 52-week low is ₹445. The current price of ₹626.5 is 18.6% below the 52W high.
What is Nephrocare Health Services Limited P/E ratio?▾
Nephrocare Health Services Limited's current P/E ratio is 83.2. This indicates the market is paying ₹83.2 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Nephrocare Health Services Limited options?▾
Nephrocare Health Services Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade NEPHROPLUS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.